A crucial role for B and T lymphocyte attenuator in preventing the development of CD4+ T cell-mediated herpetic stromal keratitis

Molecular Vision

Volumn 16, Issue , 2010, Pages 2071-2083

  Xia, Likun ^a   Zhang, Shengnan ^a   Zhou, Jiazi ^a   Li, Yan ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD272 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN D; IMMUNOSUPPRESSIVE AGENT; MEMBRANE PROTEIN; PHOSPHATE BUFFERED SALINE; PLASMID DNA; RECOMBINANT B AND T LYMPHOCYTE ATTENUATOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; CORNEA OPACITY; CYTOKINE RESPONSE; DELAYED HYPERSENSITIVITY; DISEASE SEVERITY; DNA SEQUENCE; FEMALE; FLOW CYTOMETRY; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KERATITIS; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SEQUENCE ANALYSIS; TEAR FILM; TH1 CELL; VIRUS LOAD; WESTERN BLOTTING;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CORNEA; FEMALE; GLYCOPROTEINS; HERPESVIRUS 1, HUMAN; HYPERSENSITIVITY, DELAYED; INFLAMMATION; KERATITIS, HERPETIC; MICE; MICE, INBRED BALB C; PLASMIDS; RECEPTORS, IMMUNOLOGIC; RECOMBINANT PROTEINS; RESTRICTION MAPPING; RNA, MESSENGER; TEARS; TH1 CELLS; UP-REGULATION;

EID: 78149474726     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Kaye S, Choudhary A. Herpes simplex keratitis. Prog Retin Eye Res 2006; 25:355-80.
2. Niemialtowski MG, Rouse BT. Phenotypic and functional studies on ocular T cells during herpetic infections of the eye. J Immunol 1992; 148:1864-70.
3. Niemialtowski MG, Rouse BT. Predominance of Th1 cells in ocular tissues during herpetic stromal keratitis. J Immunol 1992; 149:3035-9.
4. Deshpande S, Banerjee K, Biswas PS, Rouse BT. Herpetic eye disease: immunopathogenesis and therapeutic measures. Expert Rev Mol Med 2004; 6:1-14.
5. + T-cell type 1 and type 2 cytokines in the HSV-1 infected cornea. Graefes Arch Clin Exp Ophthalmol 1999; 237:399-406.
6. Hendricks RL, Tumpey TM, Finnegan A. IFN- and IL-2 are protective in the skin but pathologic in the corneas of HSV-1- infected mice. J Immunol 1992; 149:3023-8.
7. Tang Q, Hendricks RL. Interferon regulates platelet endothelial cell adhesion molecule 1 expression and neutrophil infiltration into herpes simplex virus-infected mouse corneas. J Exp Med 1996; 184:1435-47.
8. Chen H, Hendricks RL. B7 costimulatory requirements of T cells at an inflammatory site. J Immunol 1998; 160:5045-52.
9. Gangappa S, Manickan E, Rouse BT. Control of herpetic stromal keratitis using CTLA4Ig fusion protein. Clin Immunol Immunopathol 1998; 86:88-94.
10. Seo SK, Park HY, Choi JH, Kim WY, Kim YH, Jung HW, Kwon B, Lee HW, Kwon BS. Blocking 4-1BB/4-1BB ligand interactions prevents herpetic stromal keratitis. J Immunol 2003; 171:576-83.
11. Watanabe N, Gavrieli M, Sedy JR, Yang J, Fallarino F, Loftin SK, Hurchla MA, Zimmerman N, Sim J, Zang X, Murphy TL, Russell JH, Allison JP, Murphy KM. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat Immunol 2003; 4:670-9.
12. Sedy JR, Gavrieli M, Potter KG, Hurchla MA, Lindsley RC, Hilder K, Scheu S, Pfeffer K, Ware CF, Murphy TL, Murphy KM. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat Immunol 2005; 6:90-8.
13. Chang YH, Hsieh SL, Chao Y, Chou YC, Lin WW. Proinflammatory effects of LIGHT through HVEM and LTßR interactions in cultured human umbilical vein endothelial cells. J Biomed Sci 2005; 12:363-75.
14. M. The evolving crosstalk between co-stimulatory and coinhibitory receptors: HVEM-BELA. Trends Immunol 2005; 26:292-4.
15. + T cells. J Immunol 2005; 174:3377-85.
16. + and CD8+ T cells. J Immunol 2005; 175:6420-7.
17. + T cells. J Leukoc Biol 2010; 87:425-32.
18. Deppong C, Juehne TI, Hurchla M, Friend LD, Shah DD, Rose CM, Bricker TL, Shornick LP, Crouch EC, Murphy TL, Holtzman MJ, Murphy KM, Green JM. Cutting edge: B and T lymphocyte attenuator and programmed death receptor-1 inhibitory receptors are required for termination of acute allergic airway inflammation. J Immunol 2006; 176:3909-13.
19. Deppong C, Degnan JM, Murphy TL, Murphy KM, Green JM. B and T lymphocyte attenuator regulates T cell survival in the lung. J Immunol 2008; 181:2973-9.
20. Steinberg MW, Turovskaya O, Shaikh RB, Kim G, McCole DF, Pfeffer K, Murphy KM, Ware CF, Kronenberg M. A crucial role for HVEM and BTLA in preventing intestinal inflammation. J Exp Med 2008; 205:1463-76.
21. Babu JS, Thomas J, Kanangat S, Morrison LA, Knipe DM, Rouse BT. Viral replication is required for induction of ocular immunopathology by herpes simplex virus. J Virol 1996; 70:101-7.
22. Wasmuth S, Bauer D, Yang Y, Steuhl KP, Heiligenhaus A. Topical treatment with antisense oligonucleotides targeting tumor necrosis factor-a in herpetic stromal keratitis. Invest Ophthalmol Vis Sci 2003; 44:5228-34.
23. Keadle TL, Stuart PM. Interleukin-10 (IL-10) ameliorates corneal disease in a mouse model of recurrent herpetic keratitis. Microb Pathog 2005; 38:13-21.
24. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-??CT method. Methods 2001; 25:402-8.
25. Kim B, Sarangi PP, Azkur AK, Kaistha SD, Rouse BT. Enhanced viral immunoinflammatory lesions in mice lacking IL-23 responses. Microbes Infect 2008; 10:302-12.
26. + T cells upregulates VLA-4 and exacerbates HSV-induced corneal immunopathology. Microbes Infect 2008; 10:1192-200.
27. Lasaro MO, Ertl HC. Potentiating vaccine immunogenicity by manipulating the HVEM/BTLA pathway and other costimulatory and co-inhibitory signals of the immune system. Hum Vaccin 2009; 5:6-14.
28. + T cell responses but is dispensable for CD8 T cell responses. J Immunol 1999; 163:3194-201.
29. +0/ CD154 costimulatory interactions in host defense to primary herpes simplex virus infection. J Virol 2001; 75:612-21.
30. Sun Y, Brown NK, Ruddy MJ, Miller ML, Lee Y, Wang Y, Murphy KM, Pfeffer K, Chen L, Kaye J, Fu YX. B and T lymphocyte attenuator tempers early infection immunity. J Immunol 2009; 183:1946-51.
31. Lausch RN, Kleinschrodt WR, Monteiro C, Kayes SG, Oakes JE. Resolution of HSV corneal infection in the absence of delayed-type hepersensitivity. Invest Ophthalmol Vis Sci 1985; 26:1509-15.
32. Ksander BR, Hendricks RL. Cell- mediated immune tolerance to HSV-1 antigens associated with reduced susceptibility to HSV-1 corneal lesions. Invest Ophthalmol Vis Sci 1987; 28:1986-93.
33. Spear PG, Manoj S, Yoon M, Jogger CR, Zago A, Myscofski D. Different receptors binding to distinct interfaces on herpes simplex virus gD can trigger events leading to cell fusion and viral entry. Virology 2006; 344:17-24.
34. Akhtar J, Tiwari V, Oh MJ, Kovacs M, Kovacs SK, Valyi-Nagy T, Shukla D. HVEM and nectin-1 are the major mediators of herpes simplex virus 1 (HSV-1) entry into human conjunctival epithelium. Invest Ophthalmol Vis Sci 2008; 49:4026-35.
35. MacLeod IJ, Minson T. Binding of herpes simplex virus type-1 virions leads to the induction of intracellular signaling in the absence of virus entry. PLoS ONE 2010; 5:e9560.
36. Aubert M, Yoon M, Sloan DD, Spear PG, Jerome KR. The virological synapse facilitates herpes simplex virus entry into T cells. J Virol 2009; 83:6171-83.
37. La S, Kim J, Kwon BS, Kwon B. Herpes simplex virus type 1 glycoprotein D inhibits T-cell proliferation. Mol Cells 2002; 14:398-403.
38. Frye TD, Chiou HC, Hull BE, Bigley NJ. The efficacy of a DNA vaccine encoding herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge. Arch Virol 2002; 147:1747-59.
39. Rogers JV, Hull BE, Fink PS, Chiou HC, Bigley NJ. Murine response to DNA encoding herpes simplex virus type-1 glycoprotein D targeted to the liver. Vaccine 2000; 18:1522-30.
40. Compaan DM, Gonzalez LC, Tom I, Loyet KM, Eaton D, Hymowitz SG. Attenuating lymphocyte activity: the crystal structure of the BTLA-HVEM complex. J Biol Chem 2005; 280:39553-61.